Zoster vaccine: is newer better?

MR Kolber, T Nickonchuk - Canadian Family Physician, 2019 - cfp.ca
Recombinant zoster vaccine appears more efficacious than LZV. Over 3 years, RZV
prevents 1 additional case of herpes zoster (HZ) for about every 40 patients treated …

Update on herpes zoster vaccination: a family practitioner's guide

M Shapiro, B Kvern, P Watson, L Guenther… - Canadian Family …, 2011 - cfp.ca
Objective To answer frequently asked questions surrounding the use of the new herpes
zoster (HZ) vaccine. Sources of information Published results of clinical trials and other …

Zoster vaccine

MR Kolber, C Korownyk, T Nickonchuk - Canadian Family Physician, 2013 - cfp.ca
-Zoster (herpes zoster [HZ], shingles) incidence—vaccine 1.67%, placebo 3.42%; NNT= 58.-
Postherpetic neuralgia (PHN) incidence—vaccine 0.14%, placebo 0.42%; NNT= 358.-Seven …

Zostavax: a subcutaneous vaccine for the prevention of herpes zoster

HQ Doan, B Ung, MK Ramirez-Fort… - Expert opinion on …, 2013 - Taylor & Francis
Introduction: Herpes zoster (HZ) occurs as a reactivation of dormant varicella zoster virus
(VZV), and occurs more frequently in the aging population or the immunocompromised due …

The Importance of Zoster Prevention Vaccines

CPN Watson - Herpes Zoster: Postherpetic Neuralgia and Other …, 2017 - Springer
Herpes zoster is the commonest neurological disease [11] and is likely to increase as the
population ages. There are many complications of herpes zoster of which severe …

A vaccine to prevent herpes zoster.

KM Kessler - The New England Journal of Medicine, 2005 - europepmc.org
A vaccine to prevent herpes zoster. - Abstract - Europe PMC Sign in | Create an account
https://orcid.org Europe PMC Menu About Tools Developers Help Contact us Helpdesk Feedback …

Zoster Vaccine Works—If People Get It

S Deresinski - Infectious Disease Alert, 2013 - search.proquest.com
Herpes zoster vaccine effectiveness against incident herpes zoster and post-herpetic
neuralgia in an older US population: a cohort study. Randomized trials in the US have …

Vaccination: a new option to reduce the burden of herpes zoster

G Mick - Expert Review of Vaccines, 2010 - Taylor & Francis
There is a strong correlation between the incidence of herpes zoster (HZ) and increasing
age, with a marked rise in incidence from approximately the age of 50–60 years. The lifetime …

[HTML][HTML] Recombinant zoster vaccine for immunocompromised people

AL Cunningham - Medicine Today, 2022 - medicinetoday.com.au
People who are aged 50 years and older or who are immunocompromised are at increased
risk of herpes zoster and are recommended to receive zoster vaccine. The live attenuated …

[HTML][HTML] A new vaccine to prevent herpes zoster

JI Cohen - The New England journal of medicine, 2015 - ncbi.nlm.nih.gov
About 50% of persons will develop herpes zoster if they live to age 85 and the incidence of
zoster is increasing. While the disease may be mild in healthy young adults, persons over …